NCT01348152 - Effect of TU-100 in Patients With Functional Constipation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Functional Constipation

Interventions

DRUG

DAIKENCHUTO (TU-100)

Subjects will be randomized to 15 g/day of TU-100. Dosage is granule. Subjects will ingest two 2.5 g doses of TU-100 three times daily for 34 consecutive days.

DRUG

Placebo

Subjects will be randomized to 15 g/day of placebo. Dosage is granule. Subjects will ingest two 2.5 g doses of placebo three times daily for 34 consecutive days.

Trial Locations (1)

55407

Colon and Rectal Surgery Associates, Minneapolis